Cargando…

Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series

Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutics drug that is a drug of choice, drug desensitization protocols can be helpful. HSR can be allergic or nonallergic, but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Babaie, Delara, Shamsian, Bibi Shahin, Momtazmanesh, Nader, Godarzipour, Hamidreza, Amirmoini, Mehrdad, Bashardoust, Bahram, Ebrahimi, Masoomeh, Vahedi, Mahdieh, Ghaemi, Reza, Mesdaghi, Mehrnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706720/
https://www.ncbi.nlm.nih.gov/pubmed/31531085
http://dx.doi.org/10.22037/ijpr.1999.1100664
_version_ 1783445743047016448
author Babaie, Delara
Shamsian, Bibi Shahin
Momtazmanesh, Nader
Godarzipour, Hamidreza
Amirmoini, Mehrdad
Bashardoust, Bahram
Ebrahimi, Masoomeh
Vahedi, Mahdieh
Ghaemi, Reza
Mesdaghi, Mehrnaz
author_facet Babaie, Delara
Shamsian, Bibi Shahin
Momtazmanesh, Nader
Godarzipour, Hamidreza
Amirmoini, Mehrdad
Bashardoust, Bahram
Ebrahimi, Masoomeh
Vahedi, Mahdieh
Ghaemi, Reza
Mesdaghi, Mehrnaz
author_sort Babaie, Delara
collection PubMed
description Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutics drug that is a drug of choice, drug desensitization protocols can be helpful. HSR can be allergic or nonallergic, but the clinical manifestations are similar. RDD is effective when used appropriately, however it is often over utilized instead of performing a drug challenge. RDD is both an acceptable approach and a high-risk treatment modality in patients, in whom the offending agent is the first choice in chemotherapy. The safety of this modality has been acceptable in large studies. The side effects are often less frequent and less severe by repeating the protocol. We present 4 cases of successful desensitization in cancer patients, who have developed IgE- mediated reactions to their major chemotherapy drug.
format Online
Article
Text
id pubmed-6706720
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Shaheed Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-67067202019-09-17 Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series Babaie, Delara Shamsian, Bibi Shahin Momtazmanesh, Nader Godarzipour, Hamidreza Amirmoini, Mehrdad Bashardoust, Bahram Ebrahimi, Masoomeh Vahedi, Mahdieh Ghaemi, Reza Mesdaghi, Mehrnaz Iran J Pharm Res Original Article Usage of cancer chemotherapeutics drugs can be associated with adverse drug reactions. When IgE-mediated drug reactions are formed following administration of a chemotherapeutics drug that is a drug of choice, drug desensitization protocols can be helpful. HSR can be allergic or nonallergic, but the clinical manifestations are similar. RDD is effective when used appropriately, however it is often over utilized instead of performing a drug challenge. RDD is both an acceptable approach and a high-risk treatment modality in patients, in whom the offending agent is the first choice in chemotherapy. The safety of this modality has been acceptable in large studies. The side effects are often less frequent and less severe by repeating the protocol. We present 4 cases of successful desensitization in cancer patients, who have developed IgE- mediated reactions to their major chemotherapy drug. Shaheed Beheshti University of Medical Sciences 2019 /pmc/articles/PMC6706720/ /pubmed/31531085 http://dx.doi.org/10.22037/ijpr.1999.1100664 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Babaie, Delara
Shamsian, Bibi Shahin
Momtazmanesh, Nader
Godarzipour, Hamidreza
Amirmoini, Mehrdad
Bashardoust, Bahram
Ebrahimi, Masoomeh
Vahedi, Mahdieh
Ghaemi, Reza
Mesdaghi, Mehrnaz
Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series
title Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series
title_full Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series
title_fullStr Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series
title_full_unstemmed Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series
title_short Rapid Desensitization for Hypersensitivity Reactions to Chemotherapeutic Drugs; A Case Series
title_sort rapid desensitization for hypersensitivity reactions to chemotherapeutic drugs; a case series
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6706720/
https://www.ncbi.nlm.nih.gov/pubmed/31531085
http://dx.doi.org/10.22037/ijpr.1999.1100664
work_keys_str_mv AT babaiedelara rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT shamsianbibishahin rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT momtazmaneshnader rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT godarzipourhamidreza rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT amirmoinimehrdad rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT bashardoustbahram rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT ebrahimimasoomeh rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT vahedimahdieh rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT ghaemireza rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries
AT mesdaghimehrnaz rapiddesensitizationforhypersensitivityreactionstochemotherapeuticdrugsacaseseries